Resources

Selected
  • COVID-19
Type of publications
Regions
Diseases
Methodological quality (AMSTAR 2)
1481 results found
2021 ∙ Comité Nacional de Inmunización (CNI)
Vaccination, prevention against COVID in children under 12 years old in Bolivia
Recommendation Americas Bolivia Children COVID-19
Download:
2021 ∙ Comité Nacional de Inmunización (CNI)
Vaccination of pregnant women
Recommendation Americas Bolivia Pregnant women COVID-19
Download:
2021 ∙ SAGE
Background document on the Bharat Biotech BBV152 COVAXIN® (COVID-19) vaccine
SAGE background document COVID-19
Download:
2021 ∙ SAGE
Annexes to the interim recommendations for use of the Novavax NVX-CoV2373 vaccine against COVID-19
Evidence to recommendation table Novavax COVID-19
Download:
2021 ∙ ACIP
Adverse events among children ages 5–11 years after COVID-19 vaccination: updates from v-safe and the Vaccine Adverse Event Reporting System (VAERS)
Background paper Americas United States of America children AEFI COVID-19
Download:
2021 ∙ ATAGI
ATAGI statement on AstraZeneca vaccine in response to new vaccine safety concerns - 8 April, 2021
Recommendation Western Pacific Australia Adults Older adults Safety AstraZeneca COVID-19 vaccine COVID-19
Download:
2021 ∙ ACIP
COVID-19 Vaccine Safety Technical (VaST) Work Group
Background paper Americas United States of America vaccine safety COVID-19
Download:
2021 ∙ ACIP
Update on Omicron Variant
Background paper Americas United States of America COVID-19 variants COVID-19
Download:
2021 ∙ ACIP
Updates on Thrombosis with Thrombocytopenia Syndrome (TTS)
Background paper Americas United States of America AEFI COVID-19
Download:
2021 ∙ ACIP
Updates to the benefit/risk assessment for Janssen COVID-19 vaccines
Background paper Americas United States of America Janssen COVID-19 Vaccine COVID-19
Download:
Loading...